Announcements 2011

  In a difficult financial environment, with constant changes in the legal framework of the health sector, and especially in pharmaceuticals, Lavipharm has further strengthened its extrovert activities, aiming to an even greater growth of exports. At the same time, the company implemented its long-term plan to...

  In this environment, the consolidated turnover of Lavipharm reached 198.4 million Euros compared to 249.8 million Euros for the corresponding period in 2009. Due to the fall of pharmaceuticals' prices, Gross profit dropped to 31.7 million Euros from 39.5 million Euros in 2009. In Lavipharm,...